<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9D9A1063-04BB-45CE-89D7-2609BA29ADFA"><gtr:id>9D9A1063-04BB-45CE-89D7-2609BA29ADFA</gtr:id><gtr:firstName>Neshika</gtr:firstName><gtr:surname>Samarasekera</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900428"><gtr:id>F32D8804-E184-412B-9161-E41AB9DEBCC6</gtr:id><gtr:title>The contribution of amyloid angiopathy to intracerebral haemorrhage: a clinico-radio-pathological case-control study</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0900428</gtr:grantReference><gtr:abstractText>About one in six strokes are due to bleeding into the brain. Around 10,000 adults in the UK suffer such a bleed annually and the effects can be devastating. 50% of patients die within the first month, and those that survive are significantly functionally impaired; their quality of life is badly affected. I seek to understand more about a condition that may commonly cause such bleeding. It is called cerebral amyloid angiopathy (CAA). It occurs because the body deposits an abnormal protein called amyloid in the blood vessels of the brain. CAA is thought to cause bleeds which occur near the surface of the brain, whereas other conditions (such as high blood pressure) are assumed to cause bleeding deep within the brain. This project seeks to test these assumptions and see if brain imaging can help detect CAA. In the future, this might help to detect and treat CAA before a bleed occurs. I will compare imaging and brain tissue samples of people who have died from such bleeds with people who have died from other causes. I hope this work will help doctors to develop a more rational and effective approach to managing this devastating condition.</gtr:abstractText><gtr:technicalSummary>Background: Spontaneous intracerebral haemorrhage (ICH) affects ~10,000 adults in the UK per year, ~50% of whom die within one month. However, understanding of the causes of ICH is limited: ICH occurring deep in the brain is commonly attributed to hypertension and lobar ICH is often assumed to be due to cerebral amyloid angiopathy (CAA). My meta-analysis of existing controlled neuropathological studies revealed only a non-significant trend towards an association of CAA with ICH. Furthermore, brain microbleeds (BMBs) on magnetic resonance imaging (MRI) are thought to diagnose CAA, although there are no radiological-pathological studies of their diagnostic utility.
Aims and objectives:
(1) Create an ICH brain bank, to establish whether pathologically-proven CAA is more prevalent in lobar ICH than controls with deep ICH or age-matched controls without cerebrovascular disease.
(2) To study the presence and distribution of brain microbleeds, to determine their diagnostic utility for identifying pathologically-proven CAA, and comparison with MRI of ischaemic stroke thought to be due to small vessel diseases
Design: I will set up a two-year, community-based, prospective study of patients with ICH who are admitted to hospital or who die suddenly in the community. By obtaining MRI and autopsy tissue from subsets of this ICH cohort, and using existing imaging studies and brain tissue from participants in ischaemic stroke studies in Edinburgh, I will perform clinico-radio-pathological matched case control studies to address my aims.
Methodology: I will ascertain incident diagnoses of ICH by hot pursuit through collaboration within the local Stroke Research Network, facilitated by my participation in the local stroke service. Swift assessment will maximise the number who consent to autopsy (especially in those who die early) and consent to brain MRI at two months after onset. Brain MRIs on controls with ischaemic stroke are available from the established Edinburgh Stroke Study. Autopsy tissue on controls without cerebrovascular disease exists in the MRC Sudden Death Brain bank in Edinburgh, and tissue from patients with ischaemic stroke will be sought from participants in the Edinburgh Stroke Study.
Opportunities: The training environment, local expertise, and existing imaging and brain tissue resources make this an ideal environment for this project. Understanding the strength of the association between CAA and ICH will affect assumptions that are made about ICH cause in clinical practice. If BMBs are a sensitive and specific marker of CAA, ante mortem diagnosis would facilitate trials of treatments that slow amyloid deposition.</gtr:technicalSummary><gtr:fund><gtr:end>2013-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>209861</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>International Stroke Genetics Consortium</gtr:department><gtr:description>International Stroke Genetics Consortium</gtr:description><gtr:id>A4398170-EAB6-43EA-BF07-447F266715E2</gtr:id><gtr:impact>n.a</gtr:impact><gtr:outcomeId>jv6G9cJp6fg-1</gtr:outcomeId><gtr:partnerContribution>Other partners will also supply DNA and clinical information for a larger multicentre study of the genetic influences on stroke</gtr:partnerContribution><gtr:piContribution>Supply of DNA and anonymised clinical information taken from participants during the research fellowship for genetic studies in stroke</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Seminar on donating brains for research (Edinburgh 2013)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E5CBD78F-0B74-4BCA-9215-99C74D087987</gtr:id><gtr:impact>Approximately 30 members of public attended a talk I gave regarding my experiences of seeking consent for brain donation, format was 30 min talk and then discussion for approximately next hour.

no impacts as yet although I received positive feedback from numerous attendees.</gtr:impact><gtr:outcomeId>et6YKUJ16cw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patients with intracerebral haemorrhage</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>83805B5F-C4BA-488B-9DA8-AB294F6D1A3A</gtr:id><gtr:impact>Patient representatives attended talk that I gave which sparked discussion.

We agreed to continue these meetings because they led to thought-provoking discussions.</gtr:impact><gtr:outcomeId>qPzCV3QK2UZ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010,2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>participation in MRC Max Perutz prize</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5193A5E9-FB62-4834-9015-C4950A97249C</gtr:id><gtr:impact>Runner up in Max Perutz prize for article 'Racking our brains' which focused upon my experiences of seeking consent from patients and relatives of those who have suffered brain haemorrhages for autopsies limited to the brain.

I was able to attend a Science Writing Masterclass which sparked my interest in disseminating research to the public.</gtr:impact><gtr:outcomeId>MzunZgKCjEC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of guidelines for the management of cerebral cavernous malformations in adults</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Cavernoma Alliance</gtr:fundingOrg><gtr:id>B9634ADC-5CFE-4E3E-B552-EBAE83E31111</gtr:id><gtr:outcomeId>JJRxTkT6t9X</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Guarantors of Brain Travel awards</gtr:description><gtr:end>2010-05-02</gtr:end><gtr:fundingOrg>Guarantors of Brain</gtr:fundingOrg><gtr:id>F307A703-3E69-4F11-B9BE-1C5C538DE0CB</gtr:id><gtr:outcomeId>eRGpsSFFiqU</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>With all necessary ethical and legal approvals in place we have obtained samples of brain tissue from patients who have died from intracerebral haemorrhages. This will be analysed in due course for the presence of cerebral amyloid angiopathy</gtr:description><gtr:id>5DA26D19-2ED4-48C5-A763-18F04D28CEE5</gtr:id><gtr:impact>no impacts as yet because analysis of data is still pending.</gtr:impact><gtr:outcomeId>hjfpa13B8Nz</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Intracerebral haemorrhage brain bank</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3AE10E75-9B72-4EE0-92C1-68A8C0FF7BAE</gtr:id><gtr:title>Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6981c962662ff970fe9940bc30407e3"><gtr:id>d6981c962662ff970fe9940bc30407e3</gtr:id><gtr:otherNames>Charidimou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5a8c8aa17192d1.94541672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94436A53-005F-4B2E-83F4-BD2BA1B89341</gtr:id><gtr:title>Eligibility for randomized trials of treatments specifically for intracerebral hemorrhage: community-based study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1be6ad48864ef22d5f6d665d19f9d8d"><gtr:id>e1be6ad48864ef22d5f6d665d19f9d8d</gtr:id><gtr:otherNames>Fonville AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>doi_16398_113_001493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B737DEE3-EBF4-41E2-BF1A-51F1358DE8AB</gtr:id><gtr:title>Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64570b4d0fe7032b5370bc611a6576c7"><gtr:id>64570b4d0fe7032b5370bc611a6576c7</gtr:id><gtr:otherNames>Pasquini M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>546625a21aae12.58798429</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27EB0CA1-8D8A-4D8F-91E8-C0D5DF60BA3E</gtr:id><gtr:title>Comparative studies of the diagnosis and treatment of cerebral cavernous malformations in adults: systematic review.</gtr:title><gtr:parentPublicationTitle>Acta neurochirurgica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de514460dfbacbeeeb7a0c0549905857"><gtr:id>de514460dfbacbeeeb7a0c0549905857</gtr:id><gtr:otherNames>Poorthuis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6268</gtr:issn><gtr:outcomeId>546625d07c8998.24656758</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6DD7744-775A-4710-B423-D752022EC510</gtr:id><gtr:title>The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f041ba54d20cd57c91dc7850498fcb4"><gtr:id>8f041ba54d20cd57c91dc7850498fcb4</gtr:id><gtr:otherNames>Rodrigues MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>5a8c8aa13e2148.30358872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>842E7EA8-6B73-43CE-A631-3F9C5556495F</gtr:id><gtr:title>Imaging features of intracerebral hemorrhage with cerebral amyloid angiopathy: Systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a8c8aa1aa3e64.97690845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AF5C5CC-5A5A-4FEA-8A7D-88435CA862BB</gtr:id><gtr:title>Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome: population-based study.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn><gtr:outcomeId>56e068845590d4.94141635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>199F414F-2F1F-4D70-9CD8-E3185E3DA2C3</gtr:id><gtr:title>APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b157ef3d628d3c5e49b6db6d66e6f56d"><gtr:id>b157ef3d628d3c5e49b6db6d66e6f56d</gtr:id><gtr:otherNames>Rannikm?e K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_540e16ae16a0201f2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3A00408-6B52-4DD0-BA2E-79CCC3ED83F0</gtr:id><gtr:title>Deposition of amyloid ? in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e6064a4d07cab171f38b6cdd1227ad29"><gtr:id>e6064a4d07cab171f38b6cdd1227ad29</gtr:id><gtr:otherNames>Keable A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>568c20aac0b1d7.44319468</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0F86F1E6-A1E1-40D0-ADEF-CDE67F100713</gtr:id><gtr:title>The persisting burden of intracerebral haemorrhage: can effective treatments be found?</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e24829623af116319f10a210db3a6f44"><gtr:id>e24829623af116319f10a210db3a6f44</gtr:id><gtr:otherNames>Josephson CB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56e0690b78aea3.42586861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F233AA5-9367-46D2-B966-55338BB81D56</gtr:id><gtr:title>Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/733a5144245cb5843fc2d27daf7c603c"><gtr:id>733a5144245cb5843fc2d27daf7c603c</gtr:id><gtr:otherNames>Baharoglu MI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58bd2bac858439.50211112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>32C8054A-5D52-4A71-AF78-402232E56A04</gtr:id><gtr:title>Brain banking for neurological disorders</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_16398_13_70202_3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8BB3D02-1DFB-43EF-96FB-992D84BE85EB</gtr:id><gtr:title>Genetics of cerebral amyloid angiopathy: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b157ef3d628d3c5e49b6db6d66e6f56d"><gtr:id>b157ef3d628d3c5e49b6db6d66e6f56d</gtr:id><gtr:otherNames>Rannikm?e K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>doi_16398_012_303898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D88473CC-CD1A-4545-9D0E-6238E3198987</gtr:id><gtr:title>Genetic variants in CETP increase risk of intracerebral hemorrhage.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f954a01e509b147c22aa4f0b693a321b"><gtr:id>f954a01e509b147c22aa4f0b693a321b</gtr:id><gtr:otherNames>Anderson CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58bd2ac8bcbbe5.05893360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34AEF6E4-CCFB-4C16-8D30-85C4946314B0</gtr:id><gtr:title>The association between cerebral amyloid angiopathy and intracerebral haemorrhage: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>UZSAmBRmdDE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A185AA76-D84D-4B6E-96C0-E9EF394E0C0A</gtr:id><gtr:title>Consent for Brain Tissue Donation after Intracerebral Haemorrhage: A Community-Based Study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c861e8d45520a106ad49e9bda308d7b"><gtr:id>2c861e8d45520a106ad49e9bda308d7b</gtr:id><gtr:otherNames>Samarasekera N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675eaab37e62</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900428</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>